2[1]Prausnitz MR,Noonan JS.Permeability of cornea,sclera,and conjunctiva:A literature analysis for drug delivery to the eye[J].J Pharm Sci,1998,87(12):1479-1488.
3[2]Suhonen P,Jarvinen T,Koivisto S,et al.Different effects of pH on the permeation of pilocarpine and pilocarpine prodrugs across the isolated rabbit cornea[J].Eur J Pharm Sci,1998,6(3):169-176.
4[3]Gupta M,Majumdar DK.Effect of concentration,pH,and preservative on in vitro transcorneal permeation of ibuprofen and flurbiprofen from non-buffered aqueous drops[J].Indian J Exp Biol,1997,35(8):844-849.
5[4]Saettone MF,Chetoni P,Cerbai R,et al.Evaluation of ocular permeation enhancers:in vitro effects on corneal transport of four β-blockers,and in vitro/in vivo toxic activity[J].Int J Pharm,1996,142(1):103-113.
6[5]Sasaki H,Igarashi Y,Nagano T,et al.Different effects of absorption promoters on corneal and conjunctival penetration of ophthalmic bata-blockers[J].Pharm Res,1995,12(8):1146-1150.
7[6]Rojanasakul Y,Robinson JR.Transport mechanisms of the cornea:characterization of barrier permselectivity[J].Int J Pharm,1989,55 (2-3):237-246.
8[8]Loftsson I,Stefánsson E.Effect of cyclodextrins on topical drug delivery to the eye[J].Drug Devel Ind Pharm,1997,23(5):473-481.
9Pheyer U, Miliani SK,Dukes A,et al,Effect of topical applied antiCD4 nomoclonal antibodies on orthotopical corneal allografts in rate model[J]. Invest Ophthalmol vis sci,1995, 36(1): 52.
10pekka J,krisrinna J,Arto U,et al, The use of cyclodestrins in ophthalmic formulation of dipivefrinn[J]. Inter J pharm,1997,153(2): 225.
